🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Endometrial Endometrioid Adenocarcinoma

Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407NA1 site📍 Beijing Peking University People's Hospital · Tests: Indication-extended Fertility-sparing Therapy Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study NCT06689956n/a20 sites📍 Rochester📍 New York📍 Houston Mayo Clinic · Tests: Non-Interventional Study ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer NCT05542407Phase 11 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Atezolizumab, ONC201 Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma NCT05112601Phase 2138 sites📍 Birmingham📍 Athens📍 Augusta National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging, Nivolumab Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer NCT05080556Phase 21 site📍 London University College, London · Tests: Carboplatin Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer NCT06468215NA1 site📍 Beijing Peking University People's Hospital · Tests: Treatment Option 1 is a single-drug regimen, with oral medroxyprogesterone acetate (MPA) 500mg/d or MA 320mg/d. Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial NCT07436793Phase 24 sites📍 Iowa City📍 Albuquerque📍 Salt Lake City New Mexico Cancer Research Alliance · Tests: Biopsy Procedure, Curettage Procedure, Hysterectomy, Megestrol Acetate, Progesterone Only Hormone Replacement Therapy PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer NCT06549855NA1 site📍 Beijing Peking University People's Hospital · Tests: Sintilimab or Pembrolizumab and medroxyprogesterone acetate (MPA)/ megestrol acetate (MA) Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer NCT03422198Phase 35 sites📍 Palo Alto📍 Maywood📍 Houston University of Utah · Tests: Vaginal Cuff Brachytherapy, Short course vaginal cuff brachytherapy PROfiling Based Endometrial Cancer Adjuvant Therapy NCT05179447NA10 sites📍 Wuhan📍 Jinan📍 Hangzhou Women's Hospital School Of Medicine Zhejiang University · Tests: Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy Safety, Efficacy and Quality of Life After Adjuvant Hypofractionated Radiotherapy for Endometrial Cancer NCT07871838NA1 site📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: Hypo fractionated RT A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia NCT07107334Phase 21 site📍 Gainesville University of Florida · Tests: Glucagon-like peptide 1 receptor agonist Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites📍 La Jolla📍 San Francisco📍 Miami Beach Faeth Therapeutics · Tests: Sapanisertib, Serabelisib, Paclitaxel Molecular and ctDNA Characterization of High-Risk Endometrial Cancer NCT07062016n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) NCT06278857Phase 23 sites📍 Sydney📍 Brisbane📍 Melbourne Queensland Centre for Gynaecological Cancer · Tests: Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI] Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer NCT05231122Phase 22 sites📍 Buffalo📍 Houston Roswell Park Cancer Institute · Tests: Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Bevacizumab, Pembrolizumab, Quality-of-Life Assessment, Questionnaire A… Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer NCT05950464Phase 114 sites📍 Augusta📍 Chicago📍 Iowa City National Cancer Institute (NCI) · Tests: BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance I… Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease NCT04291612n/a18 sites📍 Hartford📍 Miami📍 Orlando Memorial Sloan Kettering Cancer Center · Tests: Physical exam
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy